13D/13G Filings - RTW INVESTMENTS LP

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, ...9, 10, 11, 12, 13
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2020-11-13
09:57 am
Purchase
2020-11-0313GFulcrum Therapeutics, Inc.
FULC
RTW INVESTMENTS LP2,071,409
7.550%
2,071,409increase
(New Position)
Filing
History
2020-10-26
2:16 pm
Purchase
2020-10-1613GTarsus Pharmaceuticals, Inc.
TARS
RTW INVESTMENTS LP2,463,601
12.790%
2,463,601increase
(New Position)
Filing
History
2020-09-28
3:59 pm
Purchase
2020-09-1813GAthira Pharma, Inc.
ATHA
RTW INVESTMENTS LP2,668,913
8.660%
2,668,913increase
(New Position)
Filing
History
2020-06-29
2:51 pm
Purchase
2020-06-1913GIVERIC bio, Inc.
ISEE
RTW INVESTMENTS LP6,121,882
8.070%
6,121,882increase
(New Position)
Filing
History
2020-06-22
09:14 am
Purchase
2020-06-1113DAvidity Biosciences, Inc.
RNA
RTW INVESTMENTS LP3,995,000
11.300%
3,995,000increase
(New Position)
Filing
History
2020-06-19
10:36 am
Purchase
2020-06-1113GCelldex Therapeutics, Inc.
CLDX
RTW INVESTMENTS LP1,885,000
9.950%
1,885,000increase
(New Position)
Filing
History
2020-06-11
08:54 am
Purchase
2020-06-0113GRelmada Therapeutics, Inc.
RLMD
RTW INVESTMENTS LP1,255,857
8.260%
1,255,857increase
(New Position)
Filing
History
2020-05-22
12:37 pm
Purchase
2020-05-1513GOyster Point Pharma, Inc.
OYST
RTW INVESTMENTS LP1,914,606
7.620%
1,914,606increase
(New Position)
Filing
History
Goto Prev, 0, 1, ...9, 10, 11, 12, 13